Divya Iyer’s track record of success began early in her career as an immunologist and clinical scientist at Merck. As the youngest leader in her clinical development team, she led programs comprising multiple Phase I-III trials across a range of therapeutic areas.

At GoodRx, Iyer has set the business strategy and go-to-market plan, helped build the sales and commercial organization and eventually took over all patient-facing commercialization initiatives for Pharma Manufacturer Solutions. Iyer has helped expand the book of business by building targeted solutions for pharma marketers, media agencies and other pharma stakeholders, driving business growth more than threefold. Her unique blend of scientific, strategic and commercial experience across several areas of the healthcare value chain have made her an invaluable asset to GoodRx.